文章名稱引用次數

• Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma19
• High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications17
• Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer15
• Prognostic Impact of miR-200 Family Members in Plasma and Exosomes from Tumor-Draining versus Peripheral Veins of Colon Cancer Patients14
• Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib12
• A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors11
• Value of Intraoperative Cytological and Pathological Sentinel Lymph Node Diagnosis in Fertility-Sparing Trachelectomy for Early-Stage Cervical Cancer11
• Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma10
• Endoscopic Diagnostic Support System for cT1b Colorectal Cancer Using Deep Learning10
• A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer9